News from shire plc A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Feb 14, 2014, 09:00 ET Shire Announces FDA Approval of Manufacturing Facility for VPRIV® (Velaglucerase Alfa for Injection) Drug Substance

LEXINGTON, MA, Feb. 14, 2014 /CNW/ - Shire plc (LSE: SHP, NASDAQ: SHPG), the global specialty biopharmaceutical company, announced today that the US Food & Drug Administration (FDA) has approved the...


Oct 22, 2012, 10:30 ET International Study Reveals Disconnect Between Patients and Healthcare Professionals (HCPs) Over Symptom Burden in Ulcerative Colitis (UC)

AMSTERDAM, Oct. 22, 2012 /CNW/ - The results of an international survey to assess patients' and healthcare professionals' (HCPs') differing perceptions of ulcerative colitis have been presented at a...


Dec 01, 2010, 05:59 ET VPRIV® (velaglucerase alfa) Approved in Canada for the Treatment of Type I
Gaucher Disease

Now available, VPRIV replaces missing enzyme in people with rare genetic disorder TORONTO, Dec. 1 /CNW Telbec/ - Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company,...


Feb 01, 2010, 08:00 ET VYVANSE(R) - new ADHD treatment option - now available in Canada

Survey reveals insights into ADHD treatment MONTREAL, Feb. 1 /CNW/ - Canadian families managing Attention Deficit Hyperactivity Disorder (ADHD) have a new treatment option. Today, Shire plc (LSE:...


Nov 17, 2009, 07:00 ET MEZADVICE(TM)* helps patients stay on track

/NOT FOR DISTRIBUTION TO U.S. MEDIA/ Shire Canada Inc. ("Shire Canada") introduces new refill reminder service for patients taking MEZAVANT(R)(xx) MONTRÉAL, Nov. 17 /CNW/ - In an effort to help...


Oct 28, 2009, 04:00 ET Shire Secures European Wide Label Extension for FOSRENOL(R) in Chronic Kidney
Disease

FOSRENOL(R) (lanthanum carbonate) Now Approved in the EU to Treat hyperphosphataemia greater than 1.78mmol/L in Chronic Kidney Disease Patients Not on Dialysis DUBLIN, Oct. 28 /CNW/ -...


Oct 07, 2009, 04:14 ET Data From a Head-to-Head Crossover Study Evaluating FOSRENOL(R) and Sevelamer
Published Today

Direct Comparison of the Two non-Calcium Phosphate Binders Gives new Insights Into Relative Efficacy DUBLIN, Oct. 7 /CNW/ - Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty...